HopeStage
Back to all studies
TerminatedNCT01113541

One-Year Trial of Oral Ziprasidone in Bipolar Patients With Metabolic Syndrome

Medication studyAges 18–65CanadaBipolarity
The study in practice

Understand this study

Who could participate?

This study is for people with bipolarity. Listed age limits: 18 years to 65 years. Other eligibility criteria apply.

Listed locations
Calgary and 9 more locationsSee all locations and recruitment
Study phase
Phase 3Usually a larger study designed to confirm effectiveness and safety in a broader group.

Get this study by email

HopeStage may email me about this study.
Loading the security check...

What to know before participating

A point to clarify

This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?

Study clarity

Things to check before joining

Study start dateJuly 2010
Recruitment status
Terminated
Enrollment listed in the registry
13
Sponsor
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
Sponsor type
Other organization
Study type
Drug
Intervention type
Drug
Study phase
Phase 3Usually a larger study designed to confirm effectiveness and safety in a broader group.
Locations
Canada
Age range
From 18 Years to 65 Years
Official registry ID
NCT01113541
Official title
Show the full official title

A One-year, Phase III, Open-label, Non-comparative Trial of the Effect of Ziprasidone HCl on Metabolic Syndrome Risk Factors in Patients With Bipolar Disorder

Recruitment & locations

Terminated

Calgary · Penticton · Winnipeg

4 more locations
  • Halifax
  • Sydney
  • Montreal
  • Sherbrooke

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is Pfizer's Upjohn has merged with Mylan to form Viatris Inc.

Does this study involve medication?

Yes. The study involves medication, including Ziprasidone HCL (oral).

Who can participate?

This study is for people with bipolarity. Listed age limits: 18 years to 65 years. Other eligibility criteria apply.

Is this study still recruiting?

The registry lists this study as terminated.

Want to explore more studies?

Explore studies